FDA pulls proposed teen tanning ban

FDA withdraws proposed ban on teen tanning beds

The FDA has withdrawn a proposed rule that would have barred Americans under age 18 from using tanning beds. The move ends the regulatory effort that would have restricted access to the devices, which have long been associated with increased risk of skin cancer.

What happened

The proposal was designed to make tanning beds off-limits for minors nationwide, reflecting growing public-health concern about ultraviolet exposure at a young age. However, the FDA pulled the rule, meaning it will not move forward as drafted.

Why it matters

• Tanning bed exposure is a major modifiable risk factor for skin cancer, and policies affecting access are a key prevention tool.
• Regulatory uncertainty can affect local action: without a federal ban, enforcement and restrictions may continue to vary by state or depend on industry and public-health initiatives.
• Public messaging remains important: even when proposals are withdrawn, the underlying health risk from UV tanning exposure does not disappear.

What’s next

No replacement federal ban was described in the coverage. It’s still important for parents, teens, and clinicians to rely on skin-cancer prevention guidance already in place—especially avoiding tanning beds and seeking safer alternatives for appearance or “sunless” color.

In short, the FDA’s withdrawal pauses a direct nationwide restriction on minors’ access, leaving the prevention approach to existing public-health education and any state-level restrictions already in force.